Kyle Frye
About Kyle Frye
Kyle Frye is the Chief Executive Officer of Cortechs.ai, where he focuses on enhancing patient care through AI solutions. He has nearly two decades of experience in the medical device industry and has held various leadership roles in sales and management.
Current Role at Cortechs.ai
Kyle Frye has been serving as the Chief Executive Officer at Cortechs.ai since 2024. In this role, he focuses on enhancing patient care through the development of AI solutions that aim to improve the detection, diagnosis, and treatment of diseases. His mission-driven approach emphasizes empowering physicians and clinicians with advanced tools to advance precision health, particularly in the area of neurological diseases.
Previous Experience at SyntheticMR
Before joining Cortechs.ai, Kyle Frye worked at SyntheticMR as President for the Americas and ANZ, as well as Chief Commercial Officer from 2021 to 2024. He led a global team that concentrated on leveraging diversity and expertise to deliver innovative solutions for clinicians and healthcare systems. His tenure at SyntheticMR followed a previous role as President and CCO from 2019 to 2021.
Sales Leadership in the Medical Device Industry
Kyle Frye has nearly two decades of experience in the medical device industry, holding various sales leadership roles. He served as Vice President of Sales for the Central Zone at Siemens Healthineers from 2018 to 2019. Additionally, he held positions at Blue Belt Technologies, Verathon Inc., and Brainlab, where he contributed to regional sales management and clinical sales strategies.
Educational Background
Kyle Frye studied at Northern Kentucky University, where he earned a bachelor's degree in Political Science and Finance from 2001 to 2004. His educational background has provided him with a foundation that supports his leadership and strategic decision-making in the healthcare sector.
Consulting Role at Picture Health
In addition to his role at Cortechs.ai, Kyle Frye has been working as a Consultant/Advisor at Picture Health since 2022. This position allows him to apply his extensive industry knowledge and experience to support the development of healthcare solutions.